Harvoni: latest news - GoINPHARMA
Monday, 25 March 2019 - 9:03


Gilead’s Sovaldi and Harvoni approved in pediatric patients

FDA approved Sovaldi and Harvoni for the treatment of pediatric patients 12 years of age and older, or weighing at least 35kg. Specifically, the drugs were approved for individuals with genotypes 1 to 6 hepatitis C, most of whom were…

Express Scripts to cover Gilead’s Harvoni

Express Scripts announced that, as of next January, it will include Gilead’s Harvoni (ledipasvir/sofosbuvir) into its Hepatitis Cure Value Program. The drug will join the AbbVie’s hepatitis C treatment Viekira Pak. The decision was taken following successful talks about Harvoni’s…